PTC shares rock­et up as Eu­ro­pean reg­u­la­tors of­fer a thumbs-up on Duchenne drug mar­ket­ing

A few days af­ter warn­ing in­vestors of the ris­ing un­cer­tain­ty it faced in the on­go­ing Eu­ro­pean re­view of its con­di­tion­al ap­proval for Translar­na, shares of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER